warf1 wtls2
Name
warf2
Label
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (SHHS2)
Description

Participant taking ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
acute coronary syndrome deep-vein thrombosis DVT pulmonary embolism WARF2
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total - 4,080 -
No - 3,470 -
Yes - 150 -
Unknown - 460 -
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 176 643 1,113 988 511 39 3,470
Yes - 4 35 68 42 1 150
Unknown 8 60 173 144 71 4 460
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,568 1,902 3,470
Yes 93 57 150
Unknown 200 260 460
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,028 232 210 3,470
Yes 134 10 6 150
Unknown 425 14 21 460